mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.5 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.5 |